Thermo Fisher $11.5 billion acquisition of QIAGEN

Overview:

• Global life sciences and laboratory applications company Thermo Fisher Scientific has made a public offer to acquire QIAGEN, a German sample preparations technology provider, in an $11.5 billion transaction. 
• QIAGEN is headquartered in the Netherlands, despite main operations taking place in Germany and is listed on both the Frankfurt and New York stock exchanges. 
• The takeover is expected to be completed in 2021.

Natasha Forrest - Researcher